retatrutide clinical trials sign up How to Get in 2026 Retatrutide is a new type

In most cases, adults may qualify for GLP-1 weight loss medications with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, prediabetes, high cholesterol, sleep apnea, or cardiovascular disease

Orforglipron, an oral GLP-1 receptor agonist for obesity (ATTAIN-1)

Larger peptides with post-translational modifications (like the fatty diacid moiety on retatrutide) are more susceptible to degradation than simpler sequences

After your target dose is reached, our health coach will discuss a diet plan customized to help you reach your weight loss goals